Abstract
Purpose
This study aimed to clarify the frequency of distal spread and the optimal distal margin after preoperative chemotherapy for advanced low rectal cancer.
Methods
The study included patients with advanced lower rectal cancer who received preoperative chemotherapy and underwent surgery during 2012–2015. We investigated the distal spread of tumor cells, defined as the distal distance from the intramucosal distal tumor edge to the farthest tumor cells located under the submucosal layer. Clinical characteristics were compared for distal spreads ≥ 10 and < 10 mm, and risk factors for distal spread ≥ 10 mm were investigated.
Results
Of the 71 patients, 42 (59%) showed distal spread. Distal spreads of 1–9, 10–19, and ≥ 20 mm were observed in 27 (38%), 11 (15%), and 4 (6%) patients, respectively. Multivariate analysis revealed two independent risk factors for distal spread ≥ 10 mm after preoperative chemotherapy. The first risk factor is the presence of different therapeutic effects between the mucosal and deeper layers (meaning that superficial tumor shrinkage was evident on colonoscopy, but little tumor shrinkage was evident on magnetic resonance imaging) (odds ratio, 11.6; 95% CI, 2.22–61.3). The second risk factor is poorly differentiated or mucinous adenocarcinoma (odds ratio, 8.86; 95% CI, 1.58–49.9).
Conclusion
A distal margin of 20 mm is required (10 mm is insufficient) for advanced lower rectal cancer patients who receive preoperative chemotherapy followed by surgery. Independent risk factors for distal spread ≥ 10 mm include (1) the presence of different therapeutic effects between mucosal and deeper layers and (2) poorly differentiated or mucinous adenocarcinomas.
Similar content being viewed by others
References
Williams NS, Dixon MF, Johnston D (1983) Reappraisal of the 5 centimetre rule of distal excision for carcinoma of the rectum: a study of distal intramural spread and of patients’ survival. Br J Surg 70:150–154
Shirouzu K, Isomoto H, Kakegawa T (1995) Distal spread of rectal cancer and optimal distal margin of resection for sphincter-preserving surgery. Cancer 76:388–392
Andreola S, Leo E, Belli F, Lavarino C, Bufalino R, Tomasic G, Baldini MT, Valvo F, Navarria P, Lombardi F (1997) Distal intramural spread in adenocarcinoma of the lower third of the rectum treated with total rectal resection and coloanal anastomosis. Dis Colon Rectum 40:25–29
Ono C, Yoshinaga K, Enomoto M, Sugihara K (2002) Discontinuous rectal cancer spread in the mesorectum and optimal distal clearance margin in situ. Dis Colon Rectum 45:744–749
Nakagoe T, Yamaguchi E, Tanaka K, Sawai T, Tsuji T, Shibasaki S, Nanashima A, Yamaguchi H, Yasutake T, Ayabe H (2003) Distal intramural spread is an independent prognostic factor for distant metastasis and poor outcome in patients with rectal cancer: a multivariate analysis. Ann Surg Oncol 10:163–170
Zhao GP, Zhou ZG, Lei WZ, Yu YY, Wang C, Wang Z, Zheng XL, Wang R (2005) Pathological study of distal mesorectal cancer spread to determine a proper distal resection margin. World J Gastroenterol 11:319–322
Shimada Y, Takii Y, Maruyama S, Ohta T (2011) Intramural and mesorectal distal spread detected by whole-mount sections in the determination of optimal distal resection margin in patients undergoing surgery for rectosigmoid or rectal cancer without preoperative therapy. Dis Colon Rectum 54:1510–1520
Komori K, Kanemitsu Y, Ishiguro S, Shimizu Y, Sano T, Ito S, Abe T, Senda Y, Misawa K, Ito Y, Uemura N, Kato T (2012) Adequate length of the surgical distal resection margin in rectal cancer: from the viewpoint of pathological findings. Am J Surg 204:474–480
Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH, Leer JW, van de Velde CJ, Dutch Colorectal Cancer Group (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638–646
Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R, German Rectal Cancer Study Group (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731–1740
Chmielik E, Bujiko K, Nasierowska-Guttmejer A, Nowacki MP, Kepka L, Sopylo R, Wojnar A, Majewski P, Sygut J, Karmolinski A, Huzarski T, Wandzel P (2006) Distal intramural spread of rectal cancer after preoperative radiotherapy: the results of a multicenter randomized clinical study. Int J Radiot Oncol Biol Phys 65:182–188
Guillem JG, Chessin DB, Shia J, Suriawinata A, Riedel E, Moore HG, Minsky BD, Wong WD (2007) A prospective pathologic analysis using whole-mount sections of rectal cancer following preoperative combined modality therapy: implications for sphincter preservation. Ann Surg 245:88–93
Hayden DM, Jakate S, Pinzon MC, Giusto D, Francescatti AB, Brand MI, Saclarides TJ (2012) Tumor scatter after neoadjuvant therapy for rectal cancer: are we dealing with an invisible margin? Dis Colon Rectum 55:1206–1212
Mezhirr JJ, Shia J, Riedel E, Temple LK, Nash GM, Weiser MR, Paty PB, Wong WD, Guillem JG (2012) Whole-mount pathologic analysis of rectal cancer following neoadjuvant therapy: implications of margin status on long-term oncologic outcome. Ann Surg 256:274–279
Ito M, Saito N, Sugito M, Kobayashi A, Nishizawa Y, Tsunoda Y (2009) Analysis of clinical factors associated with anal function after intersphincteric resection for very low rectal cancer. Dis Colon Rectum 52:64–70
Schrag D, Weiser MR, Goodman KA, Gonen M, Hollywood E, Cercek A, Reidy-Lagunes DL, Gollub MJ, Shia J, Guillem JG, Temple LK, Paty PB, Saltz LB (2014) Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: a pilot study. J Clin Oncol 32:513–518
Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, Verweij J (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228–247
Japanese Society for Cancer of the Colon and Rectum (2014) Japanese classification of colorectal carcinoma, 8th edn. Kanehara and Co., Ltd., Tokyo
Nash GM, Weiss A, Dasgupta R, Gonen M, Guillem JG, Wong WD (2010) Close distal margin and rectal cancer recurrence after sphincter-preserving rectal resection. Dis Colon Rectum 53:1365–1373
Ihn MH, Kang SB, Kim DW, Oh HK, Lee SY, Hong SM (2014) Risk factors for bowel dysfunction after sphincter-preserving rectal cancer surgery: a prospective study using the Memorial Sloan Kettering Cancer Center bowel function instrument. Dis Colon Rectum 57:958–966
National Comprehensive Cancer Network (NCCN) (2015) Colon cancer and rectal cancer guidelines, version 2. National Comprehensive Cancer Network (NCCN), Fort Washington
Kuvshinoff B, Maghfoor I, Miedema B, Bryer M, Westgate S, Wilkes J, Ota D (2001) Distal margin requirements after preoperative chemoradiotherapy for distal rectal carcinomas: are < or = 1 cm distal margins sufficient? Ann Surg Oncol 8:163–169
Moore HG, Riedel E, Minsky BD, Saltz L, Paty P, Wong D, Cohen AM, Guillem JG (2003) Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapy. Ann Surg Oncol 10:80–85
Kwak JY, Kim CW, Lim SB, Yu CS, Kim TW, Kim JH, Jang SJ, Kim JC (2012) Oncologically safe distal resection margins in rectal cancer patients treated with chemoradiotherapy. J Gastrointest Surg 16:1947–1954
Lee JH, Chie EK, Kim K, Jeong SY, Park KJ, Park JG, Kang GH, Han SW, Oh DY, Im SA, Kim TY, Bang YJ, Ha SW (2013) The influence of the treatment response on the impact of resection margin status after preoperative chemoradiotherapy in locally advanced rectal cancer. BMC Cancer 13:576
Hong KS, Moon N, Chung SS, Lee RA, Kim KH (2015) Oncologic outcome in rectal cancer with close distal resection margins: a retrospective analysis. Ann Surg Treat Res 89:23–29
Author information
Authors and Affiliations
Contributions
Akihiro Kondo, Yuichiro Tsukada, and Motohiro Kojima collected and interpreted data. Akihiro Kondo, Yuichiro Tsukada, and Masaaki Ito interpreted data and wrote the paper. Yuji Nishizawa, Takeshi Sasaki, Masaaki Ito, and Yasuyuki Suzuki made substantial contributions to the conception and design of the study, and they were involved in drafting the manuscript and revising it critically for important intellectual content. All authors declare that they contributed to this article and that they all approve its final submitted version.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.
Financial disclosure
The authors claim no conflict of interest regarding this manuscript.
Rights and permissions
About this article
Cite this article
Kondo, A., Tsukada, Y., Kojima, M. et al. Effect of preoperative chemotherapy on distal spread of low rectal cancer located close to the anus. Int J Colorectal Dis 33, 1685–1693 (2018). https://doi.org/10.1007/s00384-018-3159-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-018-3159-7